에스바이오메딕스 / 2021.03.31 사업보고서
1. 요약재무정보
가. 연결 요약 재무제표
(주)에스바이오메딕스와 그 종속기업
(단위: 원)
구 분
제 17 기(당기)
제 16 기(전기)
제 15 기(전전기)
(2020년 12월 31일)
(2019년 12월 31일)
(2018년 12월 31일)
[유동자산]
14,321,770,000,000
17,433,381,000,000
18,148,284,000,000
ㆍ현금및현금성자산
9,188,378,000,000
3,425,727,000,000
2,667,481,000,000
ㆍ매출채권
713,768,000,000
779,496,000,000
702,895,000,000
ㆍ공정가치측정금융자산
259,935,000,000
10,156,975,000,000
10,441,336,000,000
ㆍ기타유동금융자산
3,075,944,000,000
2,092,843,000,000
3,330,758,000,000
ㆍ재고자산
707,716,000,000
616,540,000,000
900,352,000,000
ㆍ기타유동자산
342,956,000,000
311,757,000,000
78,220,000,000
ㆍ당기법인세자산
33,073,000,000
50,043,000,000
27,239,000,000
[비유동자산]
3,743,330,000,000
4,850,002,000,000
4,855,419,000,000
ㆍ기타비유동금융자산
366,836,000,000
344,304,000,000
1,329,455,000,000
ㆍ유형자산
3,357,170,000,000
4,488,851,000,000
3,488,438,000,000
ㆍ무형자산
19,324,000,000
16,847,000,000
22,966,000,000
ㆍ기타비유동자산
-
-
14,557,000,000
자산총계
18,065,100,000,000
22,283,383,000,000
23,003,704,000,000
[유동부채]
6,762,601,000,000
5,547,264,000,000
4,186,707,000,000
ㆍ매입채무
505,436,000,000
579,124,000,000
211,726,000,000
ㆍ기타유동금융부채
2,057,878,000,000
2,029,018,000,000
1,471,295,000,000
ㆍ기타유동부채
486,553,000,000
345,107,000,000
120,527,000,000
ㆍ단기차입금
3,610,325,000,000
2,479,869,000,000
2,060,093,000,000
ㆍ유동성장기차입금
88,944,000,000
91,121,000,000
-
ㆍ충당부채
13,465,000,000
23,025,000,000
323,064,000,000
[비유동부채]
6,502,801,000,000
3,996,957,000,000
3,552,871,000,000
ㆍ장기차입금
2,325,143,000,000
798,303,000,000
1,685,239,000,000
ㆍ기타비유동금융부채
809,932,000,000
1,125,656,000,000
-
ㆍ확정급여부채
1,119,409,000,000
822,717,000,000
630,178,000,000
ㆍ기타비유동부채
2,062,345,000,000
1,066,515,000,000
1,070,685,000,000
ㆍ비유동충당부채
185,972,000,000
183,766,000,000
166,768,000,000
부채총계
13,265,402,000,000
9,544,221,000,000
7,739,578,000,000
[지배기업의 소유주에게 귀속되는 자본]
5,816,378,000,000
12,999,433,000,000
15,524,589,000,000
ㆍ자본금
5,074,888,000,000
1,251,222,000,000
1,191,339,000,000
ㆍ자본잉여금
43,936,135,000,000
46,747,704,000,000
41,343,531,000,000
ㆍ결손금
(45,843,849,000,000)
(38,106,329,000,000)
(29,338,774,000,000)
[비지배지분]
(1,016,680,000,000)
(260,271,000,000)
(260,463,000,000)
자본총계
4,799,698,000,000
12,739,162,000,000
15,264,125,000,000
부채와 자본총계
18,065,100,000,000
22,283,383,000,000
23,003,704,000,000
매출액
5,319,321,000,000
5,013,977,000,000
3,160,481,000,000
영업손실
(8,433,101,000,000)
(9,074,510,000,000)
(5,896,940,000,000)
당기순손실
(8,589,832,000,000)
(9,012,628,000,000)
(10,837,913,000,000)
지배기업 소유주지분
(7,747,307,000,000)
(8,097,910,000,000)
(10,837,913,000,000)
비지배지분
(842,525,000,000)
(914,719,000,000)
(636,086,000,000)
기본 및 희석주당순이익(원)
(766)
(833)
(5,308)
연결에 포함된 회사수
1
1
1
*주1) 상기 재무정보는 한국채택국제회계기준에 따라 작성되었습니다.
*주2) (주)에스테팜은 2016년 12월에 연결종속회사로 편입되었습니다.